Prognostic and predictive value of immunoscore signature in gastric cancer.

Xiaolong Qi, Yuming Jiang, Qi Zhang, Yanfeng Hu, Tuanjie Li, Jiang Yu, Liying Zhao, Gengtai Ye, Haijun Deng, Tingyu Mou, Hao Liu, Shirong Cai, Zhiwei Zhou, Guihua Chen, Guoxin LiJournal of Clinical Oncology 2017 · DOI

Abstract

e15594 Background: TNM staging system is not adequate to define the prognosis of patients with gastric cancer (GC). This system is also unable to predict whether the GC patients are likely to benefit from adjuvant chemotherapy. We postulated that ImmunoScore of GC (IS GC ) could markedly improve the prediction of postsurgical survival and adjuvant chemotherapeutic benefits. Methods: 125 GC patients were enrolled as a training cohort to detect the expression of 27 immune features using immunohistochemistry and then constructed a five-feature-based IS GC using the LASSO Cox regression model. Internal validation cohort (126 specimens) and two external validation cohorts (628 specimens) were utilized to validate the prognostic and predictive value of IS GC . Results: We established the IS GC classifier based on the five features: CD3 invasive margin (IM) , CD3 center of tumor (CT) , CD8 IM , CD45RO CT , and CD66b IM . The IS GC classifier could distinguish GC patients with high-IS GC from those with low-IS GC with significant differences in 5-year disease-free survival (45.0% v.s. 4.4%, p < 0.001) and 5-year overall survival (48.8% v.s. 6.7%, p < 0.001). According to the multivariate analysis, the IS GC classifier was proved to be an independent prognostic factor. A combination of IS GC and TNM had better prognostic value than TNM stage alone. In a further analysis, stage II and III GC patients with high-IS GC exhibited a favorable response to adjuvant chemotherapy. To provide a quantitative method to predict stage II and III GC patients’ probability of 3- and 5-year overall survival, we constructed two nomograms that integrated the IS GC and clinicopathological risk factors. Calibration plots showed that the nomograms performed well compared with an ideal model. The predictive accuracy and clinical usefulness of the nomograms were also demonstrated. Conclusions: The IS GC classifier could effectively predict recurrence and survival of GC, and complemented the prognostic value to TNM system. Moreover, the classifier might be a useful predictive tool to identify candidates with stage II and III GC who would benefit from adjuvant chemotherapy. Therefore, the IS GC might facilitate the counseling and personalize the postoperative management of GC patients.
BibTeX
@article{qi2017prognostic,
  author = {Xiaolong Qi and Yuming Jiang and Qi Zhang and Yanfeng Hu and Tuanjie Li and Jiang Yu and Liying Zhao and Gengtai Ye and Haijun Deng and Tingyu Mou and Hao Liu and Shirong Cai and Zhiwei Zhou and Guihua Chen and Guoxin Li},
  title = {{Prognostic and predictive value of immunoscore signature in gastric cancer.}},
  journal = {Journal of Clinical Oncology},
  year = {2017},
  doi = {10.1200/jco.2017.35.15\_suppl.e15594},
}

Loading related content...

Figure